0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Dasatinib Drugs - Global Market Insights and Sales Trends 2024
Published Date: November 2023
|
Report Code: QYRE-Auto-27A7844
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
United States Dasatinib Drugs Market Report Forecast 2021 2027
BUY CHAPTERS

Dasatinib Drugs - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-27A7844
Report
November 2023
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dasatinib Drugs - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Dasatinib Drugs -  Market

Dasatinib Drugs - Market

Dasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL).
The global Dasatinib Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Dasatinib Drugs in various end use industries. The expanding demands from the CML and ALL, are propelling Dasatinib Drugs market. 20mg, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the 50mg segment is estimated at % CAGR for the next seven-year period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Dasatinib Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Dasatinib Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Dasatinib Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Dasatinib Drugs sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Dasatinib Drugs covered in this report include Bristol-Myers Squibb and LUCIUS Pharma etc.
The global Dasatinib Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
LUCIUS Pharma

Scope of Dasatinib Drugs - Market Report

Report Metric Details
Report Name Dasatinib Drugs - Market
CAGR 5%
Global Dasatinib Drugs market, by region:
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Dasatinib Drugs market, Segment by Type:
  • 20mg
  • 50mg
  • 70mg
Global Dasatinib Drugs market, by Application
  • CML
  • ALL
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Two: Detailed analysis of Dasatinib Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter Three: Sales, revenue of Dasatinib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
  • Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
  • Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
  • Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter Twelve: Analysis of sales channel, distributors and customers.
  • Chapter Thirteen: Research Findings and Conclusion.

FAQ for this report

What are the Application segmentation covered in the Dasatinib Drugs - Market report?

Ans: The Applications covered in the Dasatinib Drugs - Market report are CML, ALL

What are the Type segmentation covered in the Dasatinib Drugs - Market report?

Ans: The Types covered in the Dasatinib Drugs - Market report are 20mg, 50mg, 70mg

1 Dasatinib Drugs Market Overview
1.1 Dasatinib Drugs Product Overview
1.2 Dasatinib Drugs Market Segment by Type
1.2.1 20mg
1.2.2 50mg
1.2.3 70mg
1.3 Global Dasatinib Drugs Market Size by Type
1.3.1 Global Dasatinib Drugs Market Size Overview by Type (2018-2029)
1.3.2 Global Dasatinib Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Dasatinib Drugs Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Dasatinib Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Dasatinib Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Dasatinib Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Dasatinib Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Dasatinib Drugs Sales Breakdown by Type (2018-2023)
2 Global Dasatinib Drugs Market Competition by Company
2.1 Global Top Players by Dasatinib Drugs Sales (2018-2023)
2.2 Global Top Players by Dasatinib Drugs Revenue (2018-2023)
2.3 Global Top Players by Dasatinib Drugs Price (2018-2023)
2.4 Global Top Manufacturers Dasatinib Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Dasatinib Drugs Market Competitive Situation and Trends
2.5.1 Dasatinib Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Dasatinib Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dasatinib Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into Dasatinib Drugs Market
2.8 Key Manufacturers Dasatinib Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Dasatinib Drugs Status and Outlook by Region
3.1 Global Dasatinib Drugs Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Dasatinib Drugs Historic Market Size by Region
3.2.1 Global Dasatinib Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Dasatinib Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Dasatinib Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Dasatinib Drugs Forecasted Market Size by Region
3.3.1 Global Dasatinib Drugs Sales in Volume by Region (2024-2029)
3.3.2 Global Dasatinib Drugs Sales in Value by Region (2024-2029)
3.3.3 Global Dasatinib Drugs Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Dasatinib Drugs by Application
4.1 Dasatinib Drugs Market Segment by Application
4.1.1 CML
4.1.2 ALL
4.2 Global Dasatinib Drugs Market Size by Application
4.2.1 Global Dasatinib Drugs Market Size Overview by Application (2018-2029)
4.2.2 Global Dasatinib Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Dasatinib Drugs Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Dasatinib Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Dasatinib Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Dasatinib Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Dasatinib Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Dasatinib Drugs Sales Breakdown by Application (2018-2023)
5 North America Dasatinib Drugs by Country
5.1 North America Dasatinib Drugs Historic Market Size by Country
5.1.1 North America Dasatinib Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Dasatinib Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Dasatinib Drugs Sales in Value by Country (2018-2023)
5.2 North America Dasatinib Drugs Forecasted Market Size by Country
5.2.1 North America Dasatinib Drugs Sales in Volume by Country (2024-2029)
5.2.2 North America Dasatinib Drugs Sales in Value by Country (2024-2029)
6 Europe Dasatinib Drugs by Country
6.1 Europe Dasatinib Drugs Historic Market Size by Country
6.1.1 Europe Dasatinib Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Dasatinib Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Dasatinib Drugs Sales in Value by Country (2018-2023)
6.2 Europe Dasatinib Drugs Forecasted Market Size by Country
6.2.1 Europe Dasatinib Drugs Sales in Volume by Country (2024-2029)
6.2.2 Europe Dasatinib Drugs Sales in Value by Country (2024-2029)
7 Asia-Pacific Dasatinib Drugs by Region
7.1 Asia-Pacific Dasatinib Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Dasatinib Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Dasatinib Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Dasatinib Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Dasatinib Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Dasatinib Drugs Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Dasatinib Drugs Sales in Value by Region (2024-2029)
8 Latin America Dasatinib Drugs by Country
8.1 Latin America Dasatinib Drugs Historic Market Size by Country
8.1.1 Latin America Dasatinib Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Dasatinib Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Dasatinib Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Dasatinib Drugs Forecasted Market Size by Country
8.2.1 Latin America Dasatinib Drugs Sales in Volume by Country (2024-2029)
8.2.2 Latin America Dasatinib Drugs Sales in Value by Country (2024-2029)
9 Middle East and Africa Dasatinib Drugs by Country
9.1 Middle East and Africa Dasatinib Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Dasatinib Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Dasatinib Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Dasatinib Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Dasatinib Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Dasatinib Drugs Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Dasatinib Drugs Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Dasatinib Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb Dasatinib Drugs Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 LUCIUS Pharma
10.2.1 LUCIUS Pharma Company Information
10.2.2 LUCIUS Pharma Introduction and Business Overview
10.2.3 LUCIUS Pharma Dasatinib Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 LUCIUS Pharma Dasatinib Drugs Products Offered
10.2.5 LUCIUS Pharma Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Dasatinib Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Dasatinib Drugs Industrial Chain Analysis
11.4 Dasatinib Drugs Market Dynamics
11.4.1 Dasatinib Drugs Industry Trends
11.4.2 Dasatinib Drugs Market Drivers
11.4.3 Dasatinib Drugs Market Challenges
11.4.4 Dasatinib Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Dasatinib Drugs Distributors
12.3 Dasatinib Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
List of Tables
    Table 1. Major Company of 20mg
    Table 2. Major Company of 50mg
    Table 3. Major Company of 70mg
    Table 4. Global Dasatinib Drugs Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
    Table 5. Global Dasatinib Drugs Sales by Type (2018-2023) & (K Units)
    Table 6. Global Dasatinib Drugs Sales Market Share in Volume by Type (2018-2023)
    Table 7. Global Dasatinib Drugs Sales by Type (2018-2023) & (US& Million)
    Table 8. Global Dasatinib Drugs Market Share in Value by Type (2018-2023)
    Table 9. Global Dasatinib Drugs Price by Type (2018-2023) & (USD/Unit)
    Table 10. Global Dasatinib Drugs Sales by Type (2024-2029) & (K Units)
    Table 11. Global Dasatinib Drugs Sales Market Share in Volume by Type (2024-2029)
    Table 12. Global Dasatinib Drugs Sales by Type (2024-2029) & (US$ Million)
    Table 13. Global Dasatinib Drugs Sales Market Share in Value by Type (2024-2029)
    Table 14. Global Dasatinib Drugs Price by Type (2024-2029) & (USD/Unit)
    Table 15. North America Dasatinib Drugs Sales by Type (2018-2023) & (K Units)
    Table 16. North America Dasatinib Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 17. Europe Dasatinib Drugs Sales (K Units) by Type (2018-2023)
    Table 18. Europe Dasatinib Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 19. Asia-Pacific Dasatinib Drugs Sales (K Units) by Type (2018-2023)
    Table 20. Asia-Pacific Dasatinib Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 21. Latin America Dasatinib Drugs Sales (K Units) by Type (2018-2023)
    Table 22. Latin America Dasatinib Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 23. Middle East and Africa Dasatinib Drugs Sales (K Units) by Type (2018-2023)
    Table 24. Middle East and Africa Dasatinib Drugs Sales by Type (2018-2023) & (US$ Million)
    Table 25. Global Dasatinib Drugs Sales by Company (2018-2023) & (K Units)
    Table 26. Global Dasatinib Drugs Sales Share by Company (2018-2023)
    Table 27. Global Dasatinib Drugs Revenue by Company (2018-2023) & (US$ Million)
    Table 28. Global Dasatinib Drugs Revenue Share by Company (2018-2023)
    Table 29. Global Market Dasatinib Drugs Price by Company (2018-2023) & (USD/Unit)
    Table 30. Global Dasatinib Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
    Table 31. Global Dasatinib Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Dasatinib Drugs as of 2022)
    Table 33. Date of Key Manufacturers Enter into Dasatinib Drugs Market
    Table 34. Key Manufacturers Dasatinib Drugs Product Type
    Table 35. Mergers & Acquisitions, Expansion Plans
    Table 36. Global Dasatinib Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 37. Global Dasatinib Drugs Sales by Region (2018-2023) & (K Units)
    Table 38. Global Dasatinib Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 39. Global Dasatinib Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 40. Global Dasatinib Drugs Sales Market Share in Value by Region (2018-2023)
    Table 41. Global Dasatinib Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 42. Global Dasatinib Drugs Sales by Region (2024-2029) & (K Units)
    Table 43. Global Dasatinib Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 44. Global Dasatinib Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 45. Global Dasatinib Drugs Sales Market Share in Value by Region (2024-2029)
    Table 46. Global Dasatinib Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2029)
    Table 47. Global Dasatinib Drugs Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
    Table 48. Global Dasatinib Drugs Sales by Application (2018-2023) & (K Units)
    Table 49. Global Dasatinib Drugs Sales Market Share in Volume by Application (2018-2023)
    Table 50. Global Dasatinib Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 51. Global Dasatinib Drugs Sales Market Share in Value by Application (2018-2023)
    Table 52. Global Dasatinib Drugs Price by Application (2018-2023) & (USD/Unit)
    Table 53. Global Dasatinib Drugs Sales by Application (2024-2029) & (K Units)
    Table 54. Global Dasatinib Drugs Sales Market Share in Volume by Application (2024-2029)
    Table 55. Global Dasatinib Drugs Sales by Application (2024-2029) & (US$ Million)
    Table 56. Global Dasatinib Drugs Sales Market Share in Value by Application (2024-2029)
    Table 57. Global Dasatinib Drugs Price by Application (2024-2029) & (USD/Unit)
    Table 58. North America Dasatinib Drugs Sales by Application (2018-2023) (K Units)
    Table 59. North America Dasatinib Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 60. Europe Dasatinib Drugs Sales by Application (2018-2023) (K Units)
    Table 61. Europe Dasatinib Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 62. Asia-Pacific Dasatinib Drugs Sales by Application (2018-2023) (K Units)
    Table 63. Asia-Pacific Dasatinib Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 64. Latin America Dasatinib Drugs Sales by Application (2018-2023) (K Units)
    Table 65. Latin America Dasatinib Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 66. Middle East and Africa Dasatinib Drugs Sales by Application (2018-2023) (K Units)
    Table 67. Middle East and Africa Dasatinib Drugs Sales by Application (2018-2023) & (US$ Million)
    Table 68. North America Dasatinib Drugs Sales by Country (2018-2023) & (K Units)
    Table 69. North America Dasatinib Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 70. North America Dasatinib Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 71. North America Dasatinib Drugs Sales Market Share in Value by Country (2018-2023)
    Table 72. North America Dasatinib Drugs Sales by Country (2024-2029) & (K Units)
    Table 73. North America Dasatinib Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 74. North America Dasatinib Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 75. North America Dasatinib Drugs Sales Market Share in Value by Country (2024-2029)
    Table 76. Europe Dasatinib Drugs Sales by Country (2018-2023) & (K Units)
    Table 77. Europe Dasatinib Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 78. Europe Dasatinib Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 79. Europe Dasatinib Drugs Sales Market Share in Value by Country (2018-2023)
    Table 80. Europe Dasatinib Drugs Sales by Country (2024-2029) & (K Units)
    Table 81. Europe Dasatinib Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 82. Europe Dasatinib Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 83. Europe Dasatinib Drugs Sales Market Share in Value by Country (2024-2029)
    Table 84. Asia-Pacific Dasatinib Drugs Sales by Region (2018-2023) & (K Units)
    Table 85. Asia-Pacific Dasatinib Drugs Sales Market Share in Volume by Region (2018-2023)
    Table 86. Asia-Pacific Dasatinib Drugs Sales by Region (2018-2023) & (US$ Million)
    Table 87. Asia-Pacific Dasatinib Drugs Sales Market Share in Value by Region (2018-2023)
    Table 88. Asia-Pacific Dasatinib Drugs Sales by Region (2024-2029) & (K Units)
    Table 89. Asia-Pacific Dasatinib Drugs Sales Market Share in Volume by Region (2024-2029)
    Table 90. Asia-Pacific Dasatinib Drugs Sales by Region (2024-2029) & (US$ Million)
    Table 91. Asia-Pacific Dasatinib Drugs Sales Market Share in Value by Region (2024-2029)
    Table 92. Latin America Dasatinib Drugs Sales by Country (2018-2023) & (K Units)
    Table 93. Latin America Dasatinib Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 94. Latin America Dasatinib Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 95. Latin America Dasatinib Drugs Sales Market Share in Value by Country (2018-2023)
    Table 96. Latin America Dasatinib Drugs Sales by Country (2024-2029) & (K Units)
    Table 97. Latin America Dasatinib Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 98. Latin America Dasatinib Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 99. Latin America Dasatinib Drugs Sales Market Share in Value by Country (2024-2029)
    Table 100. Middle East and Africa Dasatinib Drugs Sales by Country (2018-2023) & (K Units)
    Table 101. Middle East and Africa Dasatinib Drugs Sales Market Share in Volume by Country (2018-2023)
    Table 102. Middle East and Africa Dasatinib Drugs Sales by Country (2018-2023) & (US$ Million)
    Table 103. Middle East and Africa Dasatinib Drugs Sales Market Share in Value by Country (2018-2023)
    Table 104. Middle East and Africa Dasatinib Drugs Sales by Country (2024-2029) & (K Units)
    Table 105. Middle East and Africa Dasatinib Drugs Sales Market Share in Volume by Country (2024-2029)
    Table 106. Middle East and Africa Dasatinib Drugs Sales by Country (2024-2029) & (US$ Million)
    Table 107. Middle East and Africa Dasatinib Drugs Sales Market Share in Value by Country (2024-2029)
    Table 108. Bristol-Myers Squibb Company Information
    Table 109. Bristol-Myers Squibb Introduction and Business Overview
    Table 110. Bristol-Myers Squibb Dasatinib Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 111. Bristol-Myers Squibb Dasatinib Drugs Product
    Table 112. Bristol-Myers Squibb Recent Development
    Table 113. LUCIUS Pharma Company Information
    Table 114. LUCIUS Pharma Introduction and Business Overview
    Table 115. LUCIUS Pharma Dasatinib Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2023)
    Table 116. LUCIUS Pharma Dasatinib Drugs Product
    Table 117. LUCIUS Pharma Recent Development
    Table 118. Key Raw Materials Lists
    Table 119. Raw Materials Key Suppliers Lists
    Table 120. Dasatinib Drugs Market Trends
    Table 121. Dasatinib Drugs Market Drivers
    Table 122. Dasatinib Drugs Market Challenges
    Table 123. Dasatinib Drugs Market Restraints
    Table 124. Dasatinib Drugs Distributors List
    Table 125. Dasatinib Drugs Downstream Customers
    Table 126. Research Programs/Design for This Report
    Table 127. Key Data Information from Secondary Sources
    Table 128. Key Data Information from Primary Sources
List of Figures
    Figure 1. Dasatinib Drugs Product Picture
    Figure 2. Global Dasatinib Drugs Market Size, 2018 VS 2022 VS 2029 (US$ Million)
    Figure 3. Global Dasatinib Drugs Market Size Status and Outlook (2018-2029) & (US$ Million)
    Figure 4. Global Dasatinib Drugs Sales Status and Outlook (2018-2029) & (K Units)
    Figure 5. Product Picture of 20mg
    Figure 6. Global 20mg Sales YoY Growth (2018-2029) & (K Units)
    Figure 7. Product Picture of 50mg
    Figure 8. Global 50mg Sales YoY Growth (2018-2029) & (K Units)
    Figure 9. Product Picture of 70mg
    Figure 10. Global 70mg Sales YoY Growth (2018-2029) & (K Units)
    Figure 11. Global Dasatinib Drugs Sales by Type (2018-2029) & (US$ Million)
    Figure 12. Global Dasatinib Drugs Sales Market Share by Type in 2022 & 2029
    Figure 13. North America Dasatinib Drugs Sales Market Share in Volume by Type in 2022
    Figure 14. North America Dasatinib Drugs Sales Market Share in Value by Type in 2022
    Figure 15. Europe Dasatinib Drugs Sales Market Share in Volume by Type in 2022
    Figure 16. Europe Dasatinib Drugs Sales Market Share in Value by Type in 2022
    Figure 17. Asia-Pacific Dasatinib Drugs Sales Market Share in Volume by Type in 2022
    Figure 18. Asia-Pacific Dasatinib Drugs Sales Market Share in Value by Type in 2022
    Figure 19. Latin America Dasatinib Drugs Sales Market Share in Volume by Type in 2022
    Figure 20. Latin America Dasatinib Drugs Sales Market Share in Value by Type in 2022
    Figure 21. Middle East and Africa Dasatinib Drugs Sales Market Share in Volume by Type in 2022
    Figure 22. Middle East and Africa Dasatinib Drugs Sales Market Share in Value by Type in 2022
    Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Dasatinib Drugs Sales in 2022
    Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Dasatinib Drugs Revenue in 2022
    Figure 25. Dasatinib Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
    Figure 26. Product Picture of CML
    Figure 27. Global CML Sales YoY Growth (2018-2029) & (K Units)
    Figure 28. Product Picture of ALL
    Figure 29. Global ALL Sales YoY Growth (2018-2029) & (K Units)
    Figure 30. Global Dasatinib Drugs Sales by Application (2018-2029) & (US$ Million)
    Figure 31. Global Dasatinib Drugs Sales Market Share by Application in 2022 & 2029
    Figure 32. North America Dasatinib Drugs Sales Market Share in Volume by Application in 2022
    Figure 33. North America Dasatinib Drugs Sales Market Share in Value by Application in 2022
    Figure 34. Europe Dasatinib Drugs Sales Market Share in Volume by Application in 2022
    Figure 35. Europe Dasatinib Drugs Sales Market Share in Value by Application in 2022
    Figure 36. Asia-Pacific Dasatinib Drugs Sales Market Share in Volume by Application in 2022
    Figure 37. Asia-Pacific Dasatinib Drugs Sales Market Share in Value by Application in 2022
    Figure 38. Latin America Dasatinib Drugs Sales Market Share in Volume by Application in 2022
    Figure 39. Latin America Dasatinib Drugs Sales Market Share in Value by Application in 2022
    Figure 40. Middle East and Africa Dasatinib Drugs Sales Market Share in Value by Application in 2022
    Figure 41. Key Raw Materials Price
    Figure 42. Dasatinib Drugs Manufacturing Cost Structure
    Figure 43. Dasatinib Drugs Industrial Chain Analysis
    Figure 44. Channels of Distribution
    Figure 45. Distributors Profiles
    Figure 46. Bottom-up and Top-down Approaches for This Report
    Figure 47. Data Triangulation
    Figure 48. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3350

This license allows only one user to access the PDF.
Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS